Filtered By:
Vaccination: Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4449 results found since Jan 2013.
Triggers of Anaphylaxis in Mastocytosis Patients: Evidence of the Current Drug-Avoidance Recommendation
Opinion statementMastocytosis is associated with a high risk of anaphylaxis, in part due to drug hypersensitivity reactions (DHR). Drugs associated with mast cell activation include nonsteroidal anti-inflammatory drugs (NSAIDs), drugs used in the perioperative setting, including general anesthetics, neuromuscular blocking agents (NMBAs) and opiates/opioids, radiocontrast media (RCM), vaccines, and antibiotics such as quinolones and vancomycin. To protect patients against DHR and anaphylaxis, general avoidance of potential drug triggers is common practice, which often deprives patients of important drugs at times of need an...
Source: Current Treatment Options in Allergy - September 20, 2023 Category: Allergy & Immunology Source Type: research
Chronic Spontaneous Urticaria Following mRNA COVID-19 Booster Vaccination at a Military Academy
We present a retrospective case series of CSU following Moderna COVID-19 booster vaccinations at the US Naval Academy (USNA). Demographics, clinical features, and impact on readiness were evaluated. Forty-nine students from the USNA were evaluated for urticaria after their third COVID-19 booster vaccination. Seventeen individuals were diagnosed with CSU. The median age was 20 years and predominantly male; the median time interval between vaccination and the onset of urticaria was 11 days. Out of 13 referred to Allergy, 7 patients had CU index performed and 2 were positive. Four patients received a second booster vaccinatio...
Source: Military Medicine - September 19, 2023 Category: International Medicine & Public Health Authors: Mechelle A Miller Emily R Raffetto Rachel U Lee Source Type: research
PCPs Prep for ' Less Predictable ' Respiratory Virus Season PCPs Prep for ' Less Predictable ' Respiratory Virus Season
On the cusp of respiratory virus season, experts offer their guidance to primary care physicians about how to advise patients about vaccines for COVID-19, influenza, and RSV.Medscape Medical News
Source: Medscape Allergy Headlines - September 14, 2023 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news
Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
The Marburg virus (MV), identified in 1967, has caused deadly outbreaks worldwide, the mortality rate of Marburg virus disease (MVD) varies depending on the outbreak and virus strain, but the average case fatality rate is around 50%. However, case fatality rates have varied from 24 to 88% in past outbreaks depending on virus strain and case management. Designated a priority pathogen by the National Institute of Allergy and Infectious Diseases (NIAID), MV induces hemorrhagic fever, organ failure, and coagulation issues in both humans and non-human primates. This review presents an extensive exploration of MVD outbreak evolu...
Source: Frontiers in Microbiology - September 13, 2023 Category: Microbiology Source Type: research
Comprehensive care of adults with respiratory diseases must include vaccines
Ann Allergy Asthma Immunol. 2023 Sep;131(3):292-293. doi: 10.1016/j.anai.2023.05.023.NO ABSTRACTPMID:37661170 | DOI:10.1016/j.anai.2023.05.023
Source: Annals of Allergy, Asthma and Immunology - September 3, 2023 Category: Allergy & Immunology Authors: Barbara P Yawn Dennis Williams Gregory Poland Source Type: research
A qualitative investigation into vaccine hesitancy and confidence amongst people managing allergy
Ann Allergy Asthma Immunol. 2023 Aug 29:S1081-1206(23)01208-5. doi: 10.1016/j.anai.2023.08.600. Online ahead of print.NO ABSTRACTPMID:37652234 | DOI:10.1016/j.anai.2023.08.600
Source: Annals of Allergy, Asthma and Immunology - August 31, 2023 Category: Allergy & Immunology Authors: Ayel Luis R Batac Kaitlyn A Merrill Michael A Golding Elissa M Abrams Philippe B égin Moshe Ben-Shoshan Erika Ladouceur Leslie E Roos Vladan Protudjer Jennifer L P Protudjer Source Type: research
The top 100 most cited articles in anaphylaxis: a bibliometric analysis
Abstract Bibliometric analysis is helpful to determine the most influential studies in a specific field. A large number of publications in anaphylaxis have been published. However, no bibliometric analysis of anaphylaxis was conducted based on our known. The aim of this study is to identify the top 100 most cited articles in anaphylaxis and analyze their bibliometric characteristics. We searched in the Web of Science core database on November 20, 2021. Articles were listed in descending order by their total citations. Hence the top 100 most cited articles in anaphylaxis were identified and analyzed. Bibliometric indicators...
Source: Clinical and Experimental Medicine - August 30, 2023 Category: Research Source Type: research
A qualitative investigation into vaccine hesitancy and confidence among people managing allergy
Vaccine hesitancy is multifactorial, and among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to coronavirus disease 2019 (COVID-19) vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with a history of severe allergies. We performed semistructured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine m essaging and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research
A qualitative investigation into vaccine hesitancy and confidence amongst people managing allergy
Vaccine hesitancy has a multifactorial etiology, and, among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to COVID-19 vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with history of severe allergies. We performed semi-structured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine me ssaging, and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research
